A contamination control strategy under EU GMP Annex 1 is a documented, risk-based framework that identifies all potential contamination sources within a sterile manufacturing facility and defines the controls in place to prevent, detect, and respond to them. It applies to any manufacturer producing sterile medicinal products under EU GMP oversight. The sections below address some of the key questions Quality and EHS professionals may consider when developing, reviewing, or maintaining a contamination control strategy (CCS).
What does EU GMP Annex 1 require in a contamination control strategy?
EU GMP Annex 1 requires manufacturers to establish, maintain, and document a contamination control strategy that covers the entire sterile manufacturing process, from facility design and personnel behaviour to equipment, utilities, and environmental monitoring. The CCS must be holistic, risk-based, and continuously reviewed, rather than a static document produced once for an audit.
Annex 1 expects contamination risks to be identified and controlled through a coordinated, risk-based approach. The CCS should bring together the relevant controls across the facility and demonstrate how they contribute collectively to maintaining a state of control.
The CCS should also be reviewed as part of the pharmaceutical quality system and updated where appropriate when processes, facilities, products, risks, or monitoring trends change.
Why did the 2022 Annex 1 revision make a CCS mandatory?
The revised EU GMP Annex 1 places greater emphasis on contamination prevention, Quality Risk Management, and the interaction between controls across sterile manufacturing operations. The CCS provides a framework for bringing those controls together rather than treating areas such as facility design, gowning, cleaning, environmental monitoring, utilities, and personnel practices as separate systems. This approach is consistent with the Quality Risk Management principles described in ICH Q9, where controls are selected and reviewed according to the risks presented by the process, product, and manufacturing environment.
What are the key elements of a contamination control strategy?
Annex 1 identifies a broad range of elements that should be considered within a CCS. The exact structure and level of detail will depend on the facility, process, product, and contamination risks.
Each element should be proportionate to the classification of the area it covers. Controls appropriate for a Grade D corridor differ significantly from those required in a Grade A fill zone. The level and type of control should be proportionate to the risks associated with the area and activity.
- Facility design: HVAC systems, pressure differentials, airlock configurations, and cleanroom classifications must be documented as designed contamination controls, not just engineering specifications.
- Personnel controls: Gowning procedures, hygiene requirements, training, and entry practices should be considered alongside personnel and material movement through controlled areas.
- Process controls: Aseptic technique requirements, equipment sterilisation, and material transfer procedures form the operational core of the CCS.
- Environmental monitoring: Monitoring locations, methods, frequencies, limits, and responses should be defined and justified based on the process and contamination risks.
- Cleaning and disinfection: Schedules, validated agents, and frequency must be risk-justified and linked to the contamination sources identified in the risk assessment.
- Review mechanisms: The CCS should be periodically reviewed and reassessed when changes, adverse trends, deviations, or other relevant information indicate that existing controls may need to be reconsidered.
How does floor-level contamination fit into Annex 1 CCS requirements?
Floor-level contamination can be one of several contamination pathways considered within a facility’s risk assessment. Footwear, carts, trolleys, and other wheeled equipment may transfer particles between areas as personnel and materials move through the facility.
At entrances, gowning areas, airlocks, and material transfer points, facilities may choose to implement controls that reduce the transfer of floor-borne particulate contamination. The need for these controls should be based on the facility’s specific risks, traffic patterns, processes, and operating conditions.
Different floor-level contamination control approaches are available, including disposable adhesive mats and reusable polymeric systems. Their suitability should be evaluated based on factors such as traffic type, contamination loading, maintenance requirements, available space, waste generation, and documented performance. Annex 1 does not prescribe a specific floor mat or flooring system. Where floor-level contamination has been identified as a relevant risk, the selected control should be appropriately justified, maintained, and incorporated into the wider contamination control program.
How do you document and demonstrate CCS compliance during an audit?
During an inspection or internal review, manufacturers should be able to demonstrate how the CCS relates to the controls and records used across the facility. Supporting evidence may include SOPs, cleaning records, environmental monitoring data, gowning qualification records, maintenance documentation, risk assessments, and change-control records.
Consistency between the CCS and supporting documentation is important. If the CCS identifies a particular contamination control, the associated procedures, maintenance activities, monitoring, and records should support the way that control is described.
Practical steps to strengthen audit readiness include:
- Ensure the CCS document has a clear version history and is formally reviewed at defined intervals.
- Cross-reference each control measure to the relevant SOP, maintenance record, or monitoring programme by document number.
- Use risk assessments to make the rationale for control selection clear and traceable.
- Review relevant monitoring data for trends and document investigations where appropriate.
- Record any changes to the facility, process, or materials that prompted a CCS review and document the outcome of that review.
What’s the difference between a contamination control strategy and an environmental monitoring program?
A contamination control strategy is the overarching framework that identifies all contamination risks and defines every control measure in place to manage them. An environmental monitoring programme is one component within that framework, focused specifically on detecting contamination that has bypassed or challenged the preventive controls already in place. The CCS describes the wider approach to contamination prevention and control, while the environmental monitoring programme provides information about environmental conditions and can help identify trends, excursions, or potential weaknesses in those controls.
This distinction matters for audit purposes because inspectors expect to see both, and they expect them to be logically connected. The environmental monitoring programme should be designed based on the risk assessment within the CCS, meaning the locations, frequencies, and limits chosen for monitoring should reflect the contamination risks and control boundaries documented in the strategy.
A detailed environmental monitoring programme is therefore only one part of the overall contamination control approach. Under Annex 1, the CCS should bring together preventive controls, monitoring, quality systems, and risk-management activities into a coordinated strategy
How Dycem can support a contamination control strategy
Where floor-level particulate transfer has been identified as a relevant risk, Dycem contamination control surfaces may be used as one physical control within a wider contamination control program. Dycem’s range of contamination control mats is designed specifically to meet this need at the floor level, a frequently overlooked boundary in any sterile or controlled environment.
- Dycem CleanZone mats provide high-performance particulate and microbial capture at cleanroom entrances, gowning rooms, and airlocks, with built-in Biomaster antimicrobial protection and a documented lifespan that supports maintenance scheduling within your CCS.
- Dycem WorkZone mats address wheel-borne contamination from forklifts and pallet trucks, extending your contamination control boundary into logistics and material transfer areas.
- Dycem Floating Mats offer repositionable coverage for variable or temporary controlled zones, giving facilities the flexibility to adapt their CCS as operations evolve.
- All Dycem mats are manufactured to ISO 9001 and 14001 standards, providing the quality assurance documentation that auditors expect when reviewing physical controls referenced in a CCS.
- Dycem’s reusable mat systems are a more sustainable alternative to disposable sticky mats, reducing single-use plastic waste while delivering consistent, validatable performance.
If you are reviewing your contamination control strategy ahead of an inspection or looking to replace legacy floor-level controls with a validated, documentable solution, contact Dycem to arrange a consultation and free site survey with a contamination control specialist.
References
- European Commission. EU Guidelines for Good Manufacturing Practice, Annex 1: Manufacture of Sterile Medicinal Products. EudraLex Volume 4, 2022.
- U.S. Food and Drug Administration. Sterile Drug Products Produced by Aseptic Processing, Current Good Manufacturing Practice: Guidance for Industry.
- Pharmaceutical Inspection Co-operation Scheme. PIC/S GMP Guide, Annex 1: Manufacture of Sterile Medicinal Products.
- ICH. Q9(R1) Quality Risk Management.